Luye Pharma Group Ltd

02186

Company Profile

  • Business description

    Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company’s highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs, Central nervous system drugs and others. It derives maximum revenue from the sale of Oncology drugs.

  • Contact

    Hongqiao Road 1438
    22/F, Gubei International Fortune Center II
    Changning District
    Shanghai264003
    CHN

    T: +86 2162376350

    https://www.luye.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    5,115

Stocks News & Analysis

stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,691.802.80-0.03%
CAC 407,981.0727.300.34%
DAX 4023,278.85115.930.50%
Dow JONES (US)45,752.26386.51-0.84%
FTSE 1009,527.6520.240.21%
HKSE25,220.83614.74-2.38%
NASDAQ22,078.050.000.00%
Nikkei 22548,653.801,170.14-2.35%
NZX 50 Index13,363.9275.48-0.56%
S&P 5006,538.76103.40-1.56%
S&P/ASX 2008,421.705.200.06%
SSE Composite Index3,844.8086.25-2.19%

Market Movers